StartEngine
08/16/2022
11/15/2022
$9,995
$4,999,995
$500
Convertible Note
RegCF
$58,400,000
10%
Rolling Commitments $
Active
08/16/2022
91
0%
0%
$0
Rockville, Maryland
Healthcare & Pharmaceuticals
HealthTech
20/20 GeneSystems, with a valuation of $58.4 million, is raising funds on StartEngine. It is a diagnostics company with a successful track record in cancer detection with its AI-powered multi-cancer blood test, OneTest. The company has also launched CoronaCheck, its FDA-authorized antibody lab test for COVID-19 antibodies. The business reported revenues of $9 million in 2021, a 300% increase over 2020 revenues. Jonathan Cohen founded 20/20 GeneSystems in 2000. The current crowdfunding campaign has a minimum target of $9,995.40 and a maximum target of $4,999,995. The campaign proceeds will be used to expand the portfolio of tests and grow revenues.
Raise History
| 20/20 GeneSystems | 11/15/2022 | StartEngine | $58,400,000 | $0 | Convertible Note |
Active |
RegCF |
| 20/20 GeneSystems | 06/27/2021 | StartEngine | $38,500,000 | $2,903,017 | Equity – Preferred |
Funded |
RegA+ |
| 20/20 GeneSystems | 11/01/2020 | SeedInvest | $38,500,000 | $3,792,229 | Equity – Preferred |
Funded |
RegA+ |
| 20/20 GeneSystems | 12/14/2017 | Microventures | $23,000,000 | $1,064,807 | Equity – Preferred |
Funded |
RegCF |
